Skip to main content
eScholarship
Open Access Publications from the University of California

Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.

  • Author(s): McGrath, Michael
  • Miller, RG
  • Block, G
  • Katz, JS
  • Barohn, RJ
  • Gopalakrishnan, V
  • Cudkowicz, M
  • Zhang, JR
  • McGrath, MS
  • Ludington, E
  • Appel, SH
  • et al.

Published Web Location

http://europepmc.org/articles/PMC4396529?pdf=render
No data is associated with this publication.
Abstract

To assess the safety, tolerability, and preliminary efficacy of NP001, a novel immune regulator of inflammatory monocytes/macrophages, for slowing progression of amyotrophic lateral sclerosis (ALS).This was a phase 2 randomized, double-blind, placebo-contr

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item